University of Pittsburgh Medical Center Cancer Pavillion — Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center Cancer Pavillion is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pittsburgh Medical Center Cancer Pavillion has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: KRAS p.G12C Mutant Advanced Solid Tumors, Relapsed/Refractory Small Cell Lung Cancer, Small Cell Lung Carcinoma.

Sponsors: Amgen, Aduro Biotech, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Medical Center Cancer Pavillion?

University of Pittsburgh Medical Center Cancer Pavillion has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Medical Center Cancer Pavillion conducted?

University of Pittsburgh Medical Center Cancer Pavillion has 5 clinical trials on record, with 3 currently active. Their work covers KRAS p.G12C Mutant Advanced Solid Tumors, Relapsed/Refractory Small Cell Lung Cancer, Small Cell Lung Carcinoma.

Is University of Pittsburgh Medical Center Cancer Pavillion accredited by Crixeo Health?

University of Pittsburgh Medical Center Cancer Pavillion has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh Medical Center Cancer Pavillion?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.